Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Net Income (Quarterly) : -4.359M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.359M |
| March 31, 2026 | -1.433M |
| December 31, 2025 | -7.264M |
| September 30, 2025 | 4.678M |
| June 30, 2025 | -2.230M |
| March 31, 2025 | -4.811M |
| December 31, 2024 | -2.442M |
| September 30, 2024 | -7.824M |
| June 30, 2024 | -8.250M |
| March 31, 2024 | -8.436M |
| December 31, 2023 | -7.844M |
| September 30, 2023 | -5.206M |
| June 30, 2023 | -9.819M |
| March 31, 2023 | -8.669M |
| December 31, 2022 | 2.707M |
| September 30, 2022 | -8.255M |
| June 30, 2022 | -12.77M |
| March 31, 2022 | -7.632M |
| December 31, 2021 | -8.686M |
| September 30, 2021 | -7.113M |
| June 30, 2021 | -13.93M |
| March 31, 2021 | -5.730M |
| December 31, 2020 | -9.992M |
| September 30, 2020 | -3.941M |
| June 30, 2020 | -7.299M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.382M |
| December 31, 2019 | -5.244M |
| September 30, 2019 | -4.501M |
| June 30, 2019 | 52.22M |
| March 31, 2019 | -5.727M |
| December 31, 2018 | -5.042M |
| September 30, 2018 | -5.682M |
| June 30, 2018 | 11.81M |
| March 31, 2018 | -0.7392M |
| December 31, 2017 | 3.030M |
| September 30, 2017 | 10.60M |
| June 30, 2017 | 13.32M |
| March 31, 2017 | -3.565M |
| December 31, 2016 | -10.03M |
| September 30, 2016 | -13.05M |
| June 30, 2016 | -13.36M |
| March 31, 2016 | -12.70M |
| December 31, 2015 | -13.25M |
| September 30, 2015 | -12.41M |
| June 30, 2015 | -12.09M |
| March 31, 2015 | -9.150M |
| December 31, 2014 | 2.777M |
| September 30, 2014 | 0.7947M |
| June 30, 2014 | -4.320M |
| March 31, 2014 | -1.513M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3008M |
| Total Expenses (Quarterly) | 4.659M |
| EPS Diluted (Quarterly) | -1.112 |
| Enterprise Value | 2.554M |
| Gross Profit Margin (Quarterly) | 94.35% |
| Profit Margin (Quarterly) | -1.45K% |
| Earnings Yield | -1.45% |
| Normalized Earnings Yield | -1.448 |